Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

IMCB reported for the 3 months of 20245 by RAS

4/26/24 GEMA

Permenergosbyt reported for 3 months of 2024 by RAS

4/26/24 PMSB

Samolet reported for 2023 by IFRS

4/26/24 SMLT

Permenergosbyt reported for 2023 by IFRS

4/26/24 PMSB

IPO of MTS-Bank went over the top

4/26/24 MBNK

Board of Directors of Zaymer recommended dividends

4/26/24 ZAYM

Rusal will continue to purchase aluminum fluoride from PhosAgro until 2044

4/26/24 RUAL

Phosagro to increase supplies of aluminum fluoride to Rusal

4/26/24 PHOR

MGKL opened a store on Wildberries

4/26/24 MGKL

Shareholders of Primorie Bank approved dividends for 2023

4/26/24 PRMB